NCT02646293

Brief Summary

The incidence of the diagnosis of renal cell carcinoma has increased during the past two decades because of the detection of small renal tumours that occur incidentally because of increased use of CT-scanning (1,2). Postoperative renal insufficiency was a significant independent predictor of overall and cardiovascular specific survival (3). "Nephron-sparing" surgical techniques are now preferred for small tumor masses and laparoscopic intervention is replacing open surgery at centers that master this technique. This is an area of priority within the Regions of Zaeland and Southern Denmark. The primary endpoint is: The early plasma (5 days) \[NT-proBNP\] response predicts long-term total renal function and function of the remaining kidney. The second endpoint: Plasma \[NT-proBNP\] increases acutely after partial nephrectomy and the change reflects the renal mass reduction. Chronic blood pressure change is inversely related to plasma \[BNP\].

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 30, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 5, 2016

Completed
4 months until next milestone

Study Start

First participant enrolled

May 1, 2016

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 13, 2022

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

January 30, 2024

Status Verified

January 1, 2024

Enrollment Period

5.8 years

First QC Date

December 30, 2015

Last Update Submit

January 27, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • NT-proBNP

    5 days

Secondary Outcomes (2)

  • Partial nephrectomy_proBNP

    5 days

  • Chronic blood pressure

    12 months

Eligibility Criteria

Age25 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study is designed as an observational, longitudinal study where plasma \[NT-proBNP\], renal function and blood pressure is followed in patients undergoing partial or total nephrectomy ("nephron sparing surgery") and relate this to plasma BNP.

You may qualify if:

  • Patients suspected to have renal tumors by CT/Ultrasonic-scanning and eligible for intervention.
  • Healthy kidney donors scheduled for donation
  • Patients aged between 25 and 80 years
  • Patients can read and understand Danish

You may not qualify if:

  • Severe hypertension or congestive heart failure in New York Heart Association (NyHA) classes III-IV.
  • Renal insufficiency with glomerular filtration rate (eGFR) \<50%
  • Failure to comply

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zealand University Hospital

Roskilde, 4000, Denmark

Location

Related Publications (7)

  • Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am. 2003 Nov;30(4):843-52. doi: 10.1016/s0094-0143(03)00056-9.

  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.

  • Patel N, Sullivan M, Cranston D. Re: nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses: C. J. Weight, B. T. Larson, A. F. Fergany, T. Gao, B. R. Lane, S. C. Campbell, J. H. Kaouk, E. A. Klein and A. C. Novick J Urol 2010; 183: 1317-1323. J Urol. 2010 Nov;184(5):2213-4; author reply 2214. doi: 10.1016/j.juro.2010.06.127. Epub 2010 Sep 22. No abstract available.

  • Becker F, Van Poppel H, Hakenberg OW, Stief C, Gill I, Guazzoni G, Montorsi F, Russo P, Stockle M. Assessing the impact of ischaemia time during partial nephrectomy. Eur Urol. 2009 Oct;56(4):625-34. doi: 10.1016/j.eururo.2009.07.016. Epub 2009 Jul 28.

  • Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR Jr, Frank I, Permpongkosol S, Weight CJ, Kaouk JH, Kattan MW, Novick AC. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol. 2007 Jul;178(1):41-6. doi: 10.1016/j.juro.2007.03.038. Epub 2007 May 11.

  • Azawi NH, Christensen T. Promising early results after hand-assisted laparoscopic partial nephrectomy in carefully selected patients. Dan Med J. 2012 Oct;59(10):A4520.

  • Luchner A, Hengstenberg C, Lowel H, Riegger GA, Schunkert H, Holmer S. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension. 2005 Jul;46(1):118-23. doi: 10.1161/01.HYP.0000170140.36633.8f. Epub 2005 Jun 6.

MeSH Terms

Conditions

Kidney Diseases

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Nessn Azawi, M.D.

    Roskilde University Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Urologist

Study Record Dates

First Submitted

December 30, 2015

First Posted

January 5, 2016

Study Start

May 1, 2016

Primary Completion

February 13, 2022

Study Completion

December 31, 2022

Last Updated

January 30, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations